Gufic Biosciences incorporates wholly-owned subsidiary in UK
- India Infoline News Service |
- 17 Mar, 2022 |
- 2:57 PM
Gufic Biosciences Ltd. has incorporated a wholly-owned subsidiary called Gufic UK, United Kingdom. The new entity will support the company’s pharmaceutical business expansion in the European markets.
The cost of acquisition is 1000 pounds, consisting of 1000 equity shares of 1 pound each.
Gufic Biosciences is an emerging pharma company known for its innovative and high-quality pharmaceutical and Herbal Products along with a wide range of APIs.
Gufic is one of the largest manufacturers of Lyophilized injections in India and has a fully automated lyophilization plant. The product portfolio consists of Antibiotic, Antifungal, Cardiac, Infertility, Antiviral, and proton-pump inhibitor segments.
The cost of acquisition is 1000 pounds, consisting of 1000 equity shares of 1 pound each.
Gufic Biosciences is an emerging pharma company known for its innovative and high-quality pharmaceutical and Herbal Products along with a wide range of APIs.
Gufic is one of the largest manufacturers of Lyophilized injections in India and has a fully automated lyophilization plant. The product portfolio consists of Antibiotic, Antifungal, Cardiac, Infertility, Antiviral, and proton-pump inhibitor segments.
Gufic BioSciences is currently trading at Rs236.75 down by Rs0.25 or 0.11% from its previous closing of Rs237 on the BSE. Its scrip has touched a high and low of Rs247.35 and Rs236 respectively.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
Most Read News
- 14 March, 2022 |
- 7:03 AM
The US Federal committee's meeting will conclude on March 16, 2022.
- 26 May, 2022 |
- 8:49 AM
2023, IIFL Securities Ltd. All Rights Reserved
Follow us on
2023, IIFL Securities Ltd. All Rights Reserved
Follow us on